Study Evaluates Retatrutide in Type 2 Diabetes with Renal Impairment | Retatrutide News

A study is evaluating retatrutide's efficacy in Type 2 Diabetes patients with renal impairment. The trial, lasting about 14 months, is not recruiting ne...
Clinical Trials · October 11, 2026